335256-29-6Relevant academic research and scientific papers
Glutamate receptor antagonists
-
, (2008/06/13)
The present invention is a compound of formula wherein X is an ethynediyl group, R1, R2and R3are as defined in the specification.
Dihydro-benzo [b] [1,4] diazepin-2-one derivatives
-
, (2008/06/13)
This invention is a dihydro-benzo [b] [1,4] diazepin-2-one derivative of the formula wherein R1, R2, R3 and Y are as defined in the specification. The invention includes pharmaceutical compositions containing these compounds, a process for their preparation and a method of treatment or prevention of acute and/or chronic neurological disorders by administering an effective amount of the compound of formula I or a pharmaceuticall acceptable salt thereof.
Glutamate receptor antagonists
-
, (2008/06/13)
The present invention relates to compounds of with a base structure of formula 1 The compounds of formula I are shown to have activity as metabotropic glutamate receptor antagonists.
